281 related articles for article (PubMed ID: 25002728)
21. Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.
Sammon JD; Abdollah F; Reznor G; Pucheril D; Choueiri TK; Hu JC; Kim SP; Schmid M; Sood A; Sun M; Kibel AS; Nguyen PL; Menon M; Trinh QD
Eur Urol; 2015 Jul; 68(1):32-9. PubMed ID: 25457017
[TBL] [Abstract][Full Text] [Related]
22. Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer.
Dell'Oglio P; Boehm K; Trudeau V; Tian Z; Larcher A; Leyh-Bannurah SR; Moschini M; Capitanio U; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1037-1045. PubMed ID: 27478167
[TBL] [Abstract][Full Text] [Related]
23. An Examination of the Role of Socioeconomic Status in the Relationship between Depression and Prostate Cancer Survivorship in a Population-Based Sample of Men from Atlantic Canada.
Ilie G; Rutledge R; Sweeney E
Oncology; 2021; 99(4):260-270. PubMed ID: 33486485
[TBL] [Abstract][Full Text] [Related]
24. Survival following primary androgen deprivation therapy among men with localized prostate cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Shih W; Lin Y; DiPaola RS; Yao SL
JAMA; 2008 Jul; 300(2):173-81. PubMed ID: 18612114
[TBL] [Abstract][Full Text] [Related]
25. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013.
Fried DA; Sadeghi-Nejad H; Gu D; Zhou S; He W; Giordano SH; Pentakota SR; Demissie K; Helmer D; Shen C
Cancer Med; 2019 May; 8(5):2612-2622. PubMed ID: 30945473
[TBL] [Abstract][Full Text] [Related]
26. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Shih W; Lin Y; DiPaola RS; Yao SL
JAMA Intern Med; 2014 Sep; 174(9):1460-7. PubMed ID: 25023796
[TBL] [Abstract][Full Text] [Related]
27. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
[TBL] [Abstract][Full Text] [Related]
28. National trends in management of localized prostate cancer: A population based analysis 2004-2013.
Chen J; Oromendia C; Halpern JA; Ballman KV
Prostate; 2018 May; 78(7):512-520. PubMed ID: 29542178
[TBL] [Abstract][Full Text] [Related]
29. Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.
Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
Cancer; 2016 Oct; 122(20):3199-3206. PubMed ID: 27379732
[TBL] [Abstract][Full Text] [Related]
30. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
31. Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders.
Cabral J; Holt SK; Washington SL; Dwyer E; Lee JR; Wolff EM; Gore JL; Nyame YA
Urol Pract; 2023 Nov; 10(6):656-663. PubMed ID: 37754206
[TBL] [Abstract][Full Text] [Related]
32. Patterns and correlates of prostate cancer treatment in older men.
Roberts CB; Albertsen PC; Shao YH; Moore DF; Mehta AR; Stein MN; Lu-Yao GL
Am J Med; 2011 Mar; 124(3):235-43. PubMed ID: 21396507
[TBL] [Abstract][Full Text] [Related]
33. Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.
Aizer AA; Gu X; Chen MH; Choueiri TK; Martin NE; Efstathiou JA; Hyatt AS; Graham PL; Trinh QD; Hu JC; Nguyen PL
J Natl Compr Canc Netw; 2015 Jan; 13(1):61-8. PubMed ID: 25583770
[TBL] [Abstract][Full Text] [Related]
34. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
[TBL] [Abstract][Full Text] [Related]
35. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
Liauw SL; Ham SA; Das LC; Rudra S; Packiam VT; Koshy M; Weichselbaum RR; Becker YT; Bodzin AS; Eggener SE
J Natl Cancer Inst; 2020 Aug; 112(8):847-854. PubMed ID: 31728517
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
37. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation.
Feldman AS; Meyer CP; Sanchez A; Krasnova A; Reznor G; Menon M; Kibel AS; Choueiri TK; Lipsitz SR; Sun M; Trinh QD
J Urol; 2017 Nov; 198(5):1061-1068. PubMed ID: 28552709
[TBL] [Abstract][Full Text] [Related]
38. Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study.
Lin DW; Porter M; Montgomery B
Cancer; 2009 Jul; 115(13):2863-71. PubMed ID: 19466697
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.
Potosky AL; Haque R; Cassidy-Bushrow AE; Ulcickas Yood M; Jiang M; Tsai HT; Luta G; Keating NL; Smith MR; Van Den Eeden SK
J Clin Oncol; 2014 May; 32(13):1324-30. PubMed ID: 24638009
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
